Five things to know:
1. OrthoSpin raised $5 million in series B financing for its orthopedic fixation system.
2. Johnson & Johnson led the investment round with The Trendlines Group. OrthoSpin is part of the Trendlines portfolio.
3. This is Johnson & Johnson’s second investment in OrthoSpin; it led a $3 million investment round in July 2018.
4. OrthoSpin will use the funding to accelerate development and clinical use of its Generation 2 smart external fixation system, which is designed to reduce the need for in-person follow-up care, as well as dependency on patient compliance.
5. OrthoSpin’s Generation 1 system gained FDA clearance in September 2019. It automatically adjusts and lengthens struts in accordance with prescribed treatment regimens.
More articles on devices:
Physician group furloughs, layoffs, hours cut: economic responses to the pandemic
15 new COVID-19 cases linked to orthopedic practice in Alaska
Orthopedic surgeons among specialists called to treat COVID-19 patients in NYC
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.